scholarly article | Q13442814 |
P819 | ADS bibcode | 2013PLoSO...863918E |
P356 | DOI | 10.1371/JOURNAL.PONE.0063918 |
P932 | PMC publication ID | 3661556 |
P698 | PubMed publication ID | 23717508 |
P5875 | ResearchGate publication ID | 236959593 |
P2093 | author name string | Arrate Lasa | |
María P Portillo | |||
Itziar Eseberri | |||
Itziar Churruca | |||
P2860 | cites work | Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme | Q24299618 |
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
Resveratrol improves health and survival of mice on a high-calorie diet | Q27860950 | ||
Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha | Q28274682 | ||
Apelin stimulates glucose utilization in normal and obese insulin-resistant mice | Q28302298 | ||
Apelin, a newly identified adipokine up-regulated by insulin and obesity | Q28304725 | ||
Changes in white adipose tissue metabolism induced by resveratrol in rats | Q28567175 | ||
Effects of the obese gene product on body weight regulation in ob/ob mice | Q29617935 | ||
Role of leptin in the neuroendocrine response to fasting | Q29618866 | ||
Discordant protein and mRNA expression in lung adenocarcinomas | Q32148037 | ||
Combined effects of genistein, quercetin, and resveratrol in human and 3T3-L1 adipocytes | Q33389317 | ||
Resveratrol exerts anti-obesity effects via mechanisms involving down-regulation of adipogenic and inflammatory processes in mice. | Q53432330 | ||
Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. | Q54606528 | ||
Bioavailability and Metabolism of Resveratrol | Q59158060 | ||
Distribution of Resveratrol Metabolites in Liver, Adipose Tissue, and Skeletal Muscle in Rats Fed Different Doses of This Polyphenol | Q61875091 | ||
Plasma, urine and tissue levels of trans- and cis-resveratrol (3,4',5-trihydroxystilbene) after short-term or prolonged administration of red wine to rats | Q73139328 | ||
Regulation of leptin promoter function by Sp1, C/EBP, and a novel factor | Q74278137 | ||
Apelin, an APJ receptor ligand, regulates body adiposity and favors the messenger ribonucleic acid expression of uncoupling proteins in mice | Q79906474 | ||
Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha | Q80175296 | ||
Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus | Q84819258 | ||
Sulphation of resveratrol, a natural compound present in wine, and its inhibition by natural flavonoids | Q93942833 | ||
Resveratrol suppresses body mass gain in a seasonal non-human primate model of obesity | Q33613030 | ||
Biological effects of resveratrol | Q33841550 | ||
Pro-apoptotic versus anti-apoptotic properties of dietary resveratrol on tumoral and normal cardiac cells | Q33889566 | ||
Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites. | Q34051374 | ||
Inhibition of cancer growth by resveratrol is related to its low bioavailability | Q34139845 | ||
High absorption but very low bioavailability of oral resveratrol in humans | Q34343815 | ||
Up-regulation of adiponectin by resveratrol: the essential roles of the Akt/FOXO1 and AMP-activated protein kinase signaling pathways and DsbA-L | Q34452676 | ||
Enhanced inhibition of adipogenesis and induction of apoptosis in 3T3-L1 adipocytes with combinations of resveratrol and quercetin | Q34590988 | ||
Mechanisms of regulated unconventional protein secretion | Q34915147 | ||
Effect of Plant Polyphenols on Adipokine Secretion from Human SGBS Adipocytes. | Q35226627 | ||
Interplay of transcriptomics and proteomics | Q35603060 | ||
Pleiotropic mechanisms facilitated by resveratrol and its metabolites. | Q35692517 | ||
Obesity, hypertension and insulin resistance | Q36114431 | ||
Resveratrol: from basic science to the clinic | Q36921873 | ||
Take a break--resveratrol in action on DNA. | Q37049836 | ||
Expanding role for the apelin/APJ system in physiopathology. | Q37154640 | ||
Bioavailability of resveratrol | Q37831925 | ||
Effect of resveratrol on fat mobilization. | Q37831930 | ||
Transport, stability, and biological activity of resveratrol | Q37831931 | ||
Resveratrol, a phytochemical inducer of multiple cell death pathways: apoptosis, autophagy and mitotic catastrophe | Q37835313 | ||
Apelin, a promising target for type 2 diabetes treatment? | Q37996726 | ||
Delipidating effect of resveratrol metabolites in 3T3-L1 adipocytes. | Q42716114 | ||
Attenuation of insulin resistance, metabolic syndrome and hepatic oxidative stress by resveratrol in fructose-fed rats | Q42717892 | ||
Effects of resveratrol on the amelioration of insulin resistance in KKAy mice | Q42721580 | ||
Insulin modulates the secretion of proteins from mature 3T3-L1 adipocytes: a role for transcriptional regulation of processing | Q42798067 | ||
Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes | Q42809768 | ||
TNF-α modulates statin effects on secretion and expression of MCP-1, PAI-1 and adiponectin in 3T3-L1 differentiated adipocytes | Q42834236 | ||
Effects of different doses of resveratrol on body fat and serum parameters in rats fed a hypercaloric diet | Q43112491 | ||
Physiological increase in plasma leptin markedly inhibits insulin secretion in vivo | Q43555536 | ||
Complementary profiling of gene expression at the transcriptome and proteome levels in Saccharomyces cerevisiae | Q44049342 | ||
The inhibitory effect of resveratrol on leptin secretion from rat adipocytes. | Q45950969 | ||
Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet | Q46310539 | ||
Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase | Q46577535 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | adipocyte | Q357519 |
P304 | page(s) | e63918 | |
P577 | publication date | 2013-05-22 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Resveratrol metabolites modify adipokine expression and secretion in 3T3-L1 pre-adipocytes and mature adipocytes | |
P478 | volume | 8 |
Q42592297 | Amino Acid Carbamates As Prodrugs Of Resveratrol |
Q38245598 | Bioavailability, bioactivity and impact on health of dietary flavonoids and related compounds: an update |
Q37426494 | Combinations of bio-active dietary constituents affect human white adipocyte function in-vitro |
Q26765972 | Could gestational diabetes mellitus be managed through dietary bioactive compounds? Current knowledge and future perspectives |
Q35108724 | Development of a lozenge for oral transmucosal delivery of trans-resveratrol in humans: proof of concept |
Q38521024 | Dietary polyphenols against metabolic disorders: How far have we progressed in the understanding of the molecular mechanisms of action of these compounds? |
Q41779847 | Doses of Quercetin in the Range of Serum Concentrations Exert Delipidating Effects in 3T3-L1 Preadipocytes by Acting on Different Stages of Adipogenesis, but Not in Mature Adipocytes |
Q90052654 | EFFECT OF HYPEROSIDE ON THE INHIBITION OF ADIPOGENESIS IN 3T3-L1 ADIPOCYTES |
Q61796345 | Effects of Quercetin Metabolites on Triglyceride Metabolism of 3T3-L1 Preadipocytes and Mature Adipocytes |
Q38262965 | Enhancing the delivery of resveratrol in humans: if low bioavailability is the problem, what is the solution? |
Q35349414 | Impact of trans-resveratrol-sulfates and -glucuronides on endothelial nitric oxide synthase activity, nitric oxide release and intracellular reactive oxygen species |
Q40824062 | Limited beneficial effects of piceatannol supplementation on obesity complications in the obese Zucker rat: gut microbiota, metabolic, endocrine, and cardiac aspects. |
Q38231266 | Molecular promiscuity of plant polyphenols in the management of age-related diseases: far beyond their antioxidant properties |
Q92150454 | Natural Compounds as New Cancer Treatments |
Q42799566 | Physiologically achievable doses of resveratrol enhance 3T3-L1 adipocyte differentiation |
Q34577984 | Piceatannol and its metabolite, isorhapontigenin, induce SIRT1 expression in THP-1 human monocytic cell line |
Q59807405 | Potential Involvement of Peripheral Leptin/STAT3 Signaling in the Effects of Resveratrol and Its Metabolites on Reducing Body Fat Accumulation |
Q41457908 | Protective effects of resveratrol against streptozotocin-induced diabetes in rats by modulation of visfatin/sirtuin-1 pathway and glucose transporters. |
Q36656592 | Resveratrol and fenofibrate ameliorate fructose-induced nonalcoholic steatohepatitis by modulation of genes expression |
Q42238830 | Resveratrol attenuates triglyceride accumulation associated with upregulation of Sirt1 and lipoprotein lipase in 3T3-L1 adipocytes. |
Q42368459 | Resveratrol attenuates visfatin and vaspin genes expression in adipose tissue of rats with type 2 diabetes |
Q92743545 | Resveratrol does not affect leptin while it has regulatory effects on liver glycogen levels in exercised and non-exercised rats |
Q58614694 | Resveratrol, Metabolic Syndrome, and Gut Microbiota |
Q48061244 | Role of sulfotransferases in resveratrol metabolism in human adipocytes |
Q41102958 | Rosmarinic acid suppresses adipogenesis, lipolysis in 3T3-L1 adipocytes, lipopolysaccharide-stimulated tumor necrosis factor-α secretion in macrophages, and inflammatory mediators in 3T3-L1 adipocytes |
Q34412057 | Targeting mitochondrial alterations to prevent type 2 diabetes--evidence from studies of dietary redox-active compounds |